Latest news
Solvonis Therapeutics' SVN-015 Progresses to Advanced NIDA-Funded Preclinical Trials Following Positive Cardiac Ion-Channel Screening - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 06:00:09 GMTSolvonis’ SVN-015 Cleared for Further NIDA Studies in Stimulant Use Disorder - TipRanksTipRanks · Wed, 05 Aug 2026 07:00:00 GMT